Pamela Vig

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Foster City, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Judit Ryvkin, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Pamela Vig

Form 4 holding CHIEF SCIENTIFIC OFFICER

Mirum Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
75,000
Estimated value
$2,550,000
Report date
24 Jun 2024
Price
$34.00
Ownership
By The Vig-Ancock Family Trust
Form 4 holding CHIEF SCIENTIFIC OFFICER

Mirum Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
27,406
Estimated value
$931,804
Report date
24 Jun 2024
Price
$34.00
Ownership
Direct
Form 4 holding CHIEF SCIENTIFIC OFFICER

Mirum Pharmaceuticals, Inc.

Security class
Restricted Stock Units
Shares / value
8,000
Estimated value
$224,281
Report date
23 Jan 2024
Price
$28.04
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CHIEF SCIENTIFIC OFFICER

Mirum Pharmaceuticals, Inc.

Security class
Stock Option (right to buy)
Shares / value
125,691
Estimated value
Report date
24 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Pamela Vig

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .